[
  {
    "ts": null,
    "headline": "BMO Capital Lifts Amgen (AMGN) Price Target as MariTide Outlook Strengthens",
    "summary": "Amgen Inc. (NASDAQ:AMGN) is included among the 15 Blue Chip Dividend Stocks to Build a Passive Income Porfolio. On December 3, BMO Capital’s Evan Seigerman increased the firm’s price target on Amgen Inc. (NASDAQ:AMGN) to $372 from $335 and reiterated an Outperform rating. The analyst noted that the data from the Maritide Phase 2 Part […]",
    "url": "https://finnhub.io/api/news?id=72d397fd8ee4bb1ad34b5d2b802fbf9eeb6cc7c0b873a487310da2a82d68f4ee",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765045526,
      "headline": "BMO Capital Lifts Amgen (AMGN) Price Target as MariTide Outlook Strengthens",
      "id": 137726470,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen Inc. (NASDAQ:AMGN) is included among the 15 Blue Chip Dividend Stocks to Build a Passive Income Porfolio. On December 3, BMO Capital’s Evan Seigerman increased the firm’s price target on Amgen Inc. (NASDAQ:AMGN) to $372 from $335 and reiterated an Outperform rating. The analyst noted that the data from the Maritide Phase 2 Part […]",
      "url": "https://finnhub.io/api/news?id=72d397fd8ee4bb1ad34b5d2b802fbf9eeb6cc7c0b873a487310da2a82d68f4ee"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer on Bristol-Myers’ Recent Stock Gain: “Unbelievable”",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the stocks Jim Cramer commented on along with the recent macro rally. Cramer mentioned the stock during the episode, as he commented: “Then it might be a comeback to the drug stocks. Why? Well, remember, lots of people think the economy is stalled or in a tailspin. They’re […]",
    "url": "https://finnhub.io/api/news?id=bc52093696b6b59f6be26d1592154b8348731c3f6857af29c20e123a2def2977",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764999259,
      "headline": "Jim Cramer on Bristol-Myers’ Recent Stock Gain: “Unbelievable”",
      "id": 137715586,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the stocks Jim Cramer commented on along with the recent macro rally. Cramer mentioned the stock during the episode, as he commented: “Then it might be a comeback to the drug stocks. Why? Well, remember, lots of people think the economy is stalled or in a tailspin. They’re […]",
      "url": "https://finnhub.io/api/news?id=bc52093696b6b59f6be26d1592154b8348731c3f6857af29c20e123a2def2977"
    }
  },
  {
    "ts": null,
    "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of December 7",
    "summary": "Stay updated on Dividend Champions, Contenders, and Challengers. Review changes, ex-dividend, and pay dates.",
    "url": "https://finnhub.io/api/news?id=81d9840c52184ff00b18ae88dd7f70e73825caa975f17fd02baf431b26bd99c1",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764981045,
      "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of December 7",
      "id": 137714648,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Stay updated on Dividend Champions, Contenders, and Challengers. Review changes, ex-dividend, and pay dates.",
      "url": "https://finnhub.io/api/news?id=81d9840c52184ff00b18ae88dd7f70e73825caa975f17fd02baf431b26bd99c1"
    }
  }
]